Therapeutic Potential of Inhibiting Bruton's Tyrosine Kinase, (BTK)

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|10|15|1757-1766

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.15, 2004-06, pp. : 1757-1766

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic potential of tyrosine kinase 2 in autoimmunity

By Liang Yan   Zhu Yan   Xia Yi   Peng Hui   Yang Xiao-Ke   Liu Yan-Yan   Xu Wang-Dong   Pan Hai-Feng   Ye Dong-Qing  

Expert Opinion on Therapeutic Targets, Vol. 18, Iss. 5, 2014-05 ,pp. : 571-580

Informa Healthcare

Access to resources Recommend Favorite

PCI-32765: a novel Bruton's tyrosine kinase inhibitor for the treatment of lymphoid malignancies

By Winer Eric S   Ingham Randall R   Castillo Jorge J  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 3, 2012-03 ,pp. : 355-361

Informa Healthcare

Access to resources Recommend Favorite

Recent Updates on the Therapeutic Potential of HER2 Tyrosine Kinase Inhibitors for the Treatment of Breast Cancer

By  

Current Cancer Drug Targets, Vol. 18, Iss. 4, 2018-04 ,pp. : 306-327

Bentham Science Publishers

Access to resources Recommend Favorite

Oncogenic Variant RON160 Expression in Breast Cancer and its Potential as a Therapeutic Target by Small Molecule Tyrosine Kinase Inhibitor

By  

Current Cancer Drug Targets, Vol. 13, Iss. 6, 2013-07 ,pp. : 686-697

Bentham Science Publishers

Access to resources Recommend Favorite

Polio vaccine live oral: Vaccine-associated paralytic poliomyelitis in an infant with a Bruton's tyrosine kinase mutation: case report

By  

Reactions Weekly, Vol. 1, Iss. 1225, 2008-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite